Introduction
Metabolic diseases such as obesity and type 2 diabetes result from a variable combination of genetic and environmental factors [1 ] . Although it appears obvious that a mutation on a gene coding for a key molecular factor involved in the control of energy metabolism can lead to diabetes or obesity, the molecular events allowing environmental factors to provoke the same pathological consequences are poorly understood. Nowadays, the growing epidemic of obesity and type 2 diabetes has prompted the scientific community to develop or identify new therapeutic targets. The excessive energy intake, as well as the reduction of physical activity, are certainly two environmental factors classically associated with the development of metabolic diseases. When a population is overfed or subjected to the same nutritional stress, however, some individuals are less susceptible to diet-induced weight gain and hyperglycemia [2, 3] . This observation suggests that other mechanisms are involved which are not directly related to the human genome. The intestinal flora was recently proposed as an environmental factor responsible for the control of body weight and energy metabolism. The aim of this review is to highlight how the modulation of gut microbiota affects the energy metabolism.
The human gut microbiota: we are not alone
The human gastrointestinal tract contains a diverse collection of microorganisms, the majority of which reside in the colon. The human gut contains around 10 14 bacterial cells and up to 1000 species, which exceeds the largest microbial community associated with the human body [4] . Thus, it seems easy to view ourselves as an amalgam of genes embedded in our human genome and in the genomes of our microbial partners (microbiome), hence becoming the 'metagenome' [5 ] . As a whole, the microbiome represents more than 100 times the human genome [6 ,7] . What is becoming clear is that this microbiota and its microbiome provide us with genetic and metabolic attributes, sparing us from the need to evolve on our own. This change involves several linked mechanisms, including defence against pathogens at the gut level, immunity (mediated through a number of signal molecules and metabolites), the development of the intestinal microvilli, the fermentation of nondigestible dietary fiber and related nutrients (resistant starch or oligosaccharides), the anaerobic metabolism of peptides and proteins, the biotransformation of conjugated bile acids, the degradation of oxalate-based complexes, and the synthesis of some vitamins (e.g. B12 and K) [8] . Thus, the gut microbiota can be considered an 'exteriorized organ' which contributes to our homeostasis; its functions are multiple and largely diverse. Intuitively, the major part of the microbiota is present at a point in the gut where food products escaped digestion in the upper part of the gastrointestinal tract. Gut bacteria have genomic characteristics which allow them to use these 'providential' nutrients. As a feedback, they also intervene in host metabolism to provide energy through the production of metabolites absorbed by colonic host cells (short chain fatty acids), but also through more indirect ways, as explained further below. The vast majority of bacterial species within the gut are as yet uncultured and are not represented in studies using cultured-based microbiology. More recently, information on microbial diversity within this community has been expanded as a result of 16S rRNA-based analyses, as demonstrated by several studies highlighting the evolutionary and functional aspects of microbial diversity in the human gut [6 ,9,10 ,11 ]. Most mechanistic and metagenomics studies have been performed in animal models. The latter help to eliminate many of the confounding variables (environment, diet and genotype), which would make such a proof of principle experiment impossible to perform and therefore to interpret in humans. Several new mechanistic studies performed in humans, however, will also be discussed in the present review.
Gut microbiota and energy balance
The biological functions controlled by the intestinal flora seem to relate to the effectiveness of energy harvest, by the bacteria, of the energy ingested but not digested by the host. The control of body weight depends on mechanisms subtly controlled over time. Less than 1% of excess in energy intake compared with the daily expenditure, however, can lead to a detrimental increase in body weight and metabolic complications in the long term (several years) [12] . Consequently, all the mechanisms influencing food-derived energy availability should contribute to the balance of body weight. Several studies from the group of J. Gordon (St Louis, Missouri, USA) have highlighted that gut microflora composition is involved in the regulation of energy homeostasis [5 ,13,14,15 ,16] . A few years ago, Backhed et al. [13] found that young conventionally reared mice have a 40% higher body fat content and 47% higher gonadal fat content than germ-free mice. Strikingly, this phenomenon was associated with a lower food intake in mice with the conventional microbiota than in their germ-free counterparts. In the same line, the authors demonstrated that germ-free mice colonized with the gut microflora derived from the conventional mice increased their fat mass by about 60% and developed insulin resistance within 2 weeks. The mechanisms of the apparent gain in weight implied, firstly, an increase in the intestinal glucose absorption; secondly, energy extraction from nondigestible food components (short chain fatty acids produced through the fermentation); and thirdly, concomitant higher glycemia and insulinemia, two key metabolic factors promoting lipogenesis. Interestingly, the conventionalization also brought about a general increase in the activity of the enzyme lipoprotein lipase (LPL), catalyzing the release of fatty acids from triacylglycerols associated with lipoproteins, which are then taken up by the muscle and adipose tissues. The authors proposed that such an increase was the consequence of suppressing the fasting-induced adipose factor (FIAF) in the gut. FIAF inhibits LPL activity, and therefore, decreasing FIAF in conventionalized germ-free mice leads to the accumulation of triacylglycerol in the adipose tissue. These experiments demonstrated for the first time that an environmental factor such as gut microbiota regulates energy storage [13] .
Ley et al. [14] demonstrated, in a rodent model, that obesity can be associated with altered gut microflora. After the characterization of more than 5000 bacterial 16sRNA gene sequences from gut microbiota of genetically obese ob/ob mice and their lean counterparts, the authors pointed out that obese animals had a 50% reduction in the abundance of Bacteroidetes and a proportional increase in Firmicutes. The observed alterations in the microbiota community may represent an unheralded contributing factor to the pattern of fuel partitioning between lean and obese mice. Accordingly, these authors [15 ] have also compared the distal gut microbiota of obese and lean humans. In order to investigate the relationship between gut microbial ecology and body fat mass in humans, they studied 12 obese volunteers assigned to a fat-restricted or a carbohydraterestricted low-energy diet. They found that before therapy, obese people had lower Bacteroidetes and more Firmicutes than lean controls.
The results, obtained both in rodents and humans, suggest that obesity alters the composition of the gut microbiota, but they did not prove that the relative difference in bacterial strains distribution leads to different body weight evolution. To test this hypothesis, the same group performed a clear-cut experiment in which the gut microbiota from ob/ob mice was transferred to lean germ-free mice. They found that after only 2 weeks, lean mice colonized with the microbiota from obese mice had a modest fat gain, and extracted more energy from their food compared with the mice colonized with the gut microbiota from lean mice [5 ] . Together, these data suggest that the differences between both groups of lean mice, in terms of fat and body weight gain, may be attributable to the change in gut microbiota.
This original idea that gut bacteria can contribute to the evolution of body weight is a matter of debate. It is not clear, however, whether a small modification in energy extraction can actually contribute to a meaningful difference in body weight within a short period of time, as suggested in gut flora transplantation studies. In fact, the difference in fat mass observed between the lean germ-free mice receiving the 'obese gut microbiota' and those given the 'lean gut microbiota' is so small that it could be accounted for entirely by the tiny differences in food intake rather than the energy extraction efficiency itself [16] . In addition, our group and others [17] [18] [19] [20] [21] have clearly shown that a food rich in fermentable nondigestible fibers decreases body weight, fat mass and the severity of diabetes. These fibers are highly fermented in the caeco-colon, promoting the development of some specific strains of bacteria able to use the fibers as an energy source, thus increasing the total amount of bacteria in the colon [22, 23, 24 ]. This observation is not completely in favor of the hypothesis that the digestion of the fibres/polysaccharides by gut microbiota would support the gain in weight by increasing the supply of energy to the organism. It rather, supports the fact that a specific modulation of gut microbiota, even if not yet well characterized, may have beneficial consequences for the host. A last crucial point, which cannot depend only on the role played by the bacteria to harvest energy from nutrients escaping digestion in the upper part of the intestine, concerns a study showing that germ-free mice are more resistant to dietinduced obesity [25] . The authors maintained germ-free mice or conventionalized mice on a high-fat/highcarbohydrates diet (western diet). They found that conventionalized animals fed the western diet gained significantly more weight and fat mass than the germ-free mice, and showed higher glycemia and insulinemia. Strikingly, and opposite to the results previously observed in germ-free mice fed a normal chow diet, germ-free mice consumed similar amounts of western diet than the conventionalized mice and had a similar fecal energy output. All these data suggest that a bacterially related factor is responsible for the development of diet-induced obesity and diabetes.
Gut microbiota-related factor responsible for obesity and type 2 diabetes
Recently, a new hypothesis linking gut microflora to metabolic homeostasis has been proposed. Type 2 diabetes and obesity are closely associated to a low-tone inflammatory state in response to being fed a high-fat diet [26, 27 ]. We have been investigating whether a bacterially related factor may be responsible for the development of obesity, diabetes and inflammation induced by a high-fat diet. We found that the bacterial lipopolysaccharide from the Gram-negative intestinal microbiota would fulfil all the prerequisites to be eligible. Lipopolysaccharide is continuously produced in the gut through the lysis of Gram-negative bacteria and is physiologically absorbed and transported from the intestine toward target tissues by a lipoprotein-dependent mechanism [28, 29] . Moreover, lipopolysaccharide triggers the secretion of proinflammatory cytokines when it binds to the complex of CD14/TLR4 at the surface of immune cells [30] . In support of this concept and by the modulation of the gut microflora by a change in dietary habits, we demonstrated that high-fat diet feeding resulted in a significant modulation of the dominant bacterial populations within the gut microflora. We observed a reduction in the number of bifidobacteria, Eu. Recatle/Cl. Coccoides group and Bacteroides-related mouse intestinal bacteria, which favored an increase in the Gram-negative/Gram-positive ratio. This profound modulation of gut microflora was associated with a significant increase in plasma lipopolysaccharide, fat mass and body weight gain, liver hepatic triglyceride accumulation, diabetes and inflammatory tone [31] . To demonstrate that bacterial lipopolysaccharide could act as a triggering factor, CD14 mutant mice were fed a high-fat diet. We found that, in the absence of the lipopolysaccharide receptor, mice resisted all the metabolic disorders induced by the high-fat dietary treatment. In line with our findings, recent studies have reported that plasma lipopolysaccharide is increased in ob/ob and db/db mice [32 ] . Furthermore, polymyxin B treatment, which specifically eliminates Gram-negative bacteria, further quenches lipopolysaccharide and lessens hepatic steatosis [33] . Importantly, such a conclusion is also supported by an epidemiological study in humans [31] in which healthy individuals fed a fat-enriched diet were characterized by a higher fasting endotoxemia, independently of the other macronutrient intake (proteins or carbohydrates). Creely et al. [34 ] recently reinforced the hypothesis that lipopolysaccharide may act as a gut microbiota-related factor involved in the development of type 2 diabetes and obesity in humans. The authors found that plasma lipopolysaccharide levels were significantly higher in the BMI, sex, and age-matched type 2 diabetes patients group than in the individuals without diabetes. Furthermore, fasting insulin significantly correlated with lipopolysaccharide level in the whole nondiabetic population, and this correlation remained when controled for sex, age, and BMI.
All these studies strongly suggest a potential role for a gut microflora derived factor (namely lipopolysaccharide) in the pathogenesis of obesity-related type 2 diabetes and the innate immune response.
Dietary modulation of gut microflora and metabolic consequences
Among the tools used to modulate the gut microflora, prebiotics and probiotics are of the most importance, as recently reviewed by Macfarlane et al. [35 ] . A prebiotic is ''a selectively fermented ingredient that allows specific Gut microflora as a target for energy and metabolic homeostasis Cani and Delzenne 731 changes, both in the composition of and/or the activity in the gastrointestinal microflora that confers benefits upon host well being and health'' [36] ; it contains live flora given orally in quantities adequate to allow the colonization of the colon. Inulin-type fructooligosaccharides, when taken in the diet in relatively small amounts (5-20 g/day), have been clearly shown in human studies to stimulate growth of health-promoting species belonging to the genera Bifidobacterium spp. and Lactobacillus spp. [35 ] . Since Bifidobacteria was found to reduce the intestinal endotoxin levels and improve mucosal barrier function [37,38 ,39] , then dietary supplementation with the prebiotic oligofructose restores the numbers of Bifidobacterium spp. in mice having a high-fat diet-induced altered gut microflora [40] . Mice fed the prebiotic dietary fibers exhibited normalized plasma lipopolysaccharide levels. This observation strongly correlated with a normal inflammatory tone, an improved glucose tolerance and normal glucose-induced insulin secretion in prebiotic fed mice. Therefore, these experimental data support the role of the gut microflora as a putative target to maintain or restore metabolic functions. Among the dietary interventions devoted to reducing body weight gain, food intake, hepatic steatosis and associated metabolic disorders in humans, several studies have already shown that an increase in Bifidobacteria by means of prebiotics seems to be clearly effective [20, [41] [42] [43] . In addition to the modulation of energy and metabolism by gut microflora, one should bear in mind the possibility that the conversion of dietary components by intestinal bacteria may lead to the formation of a large variety of metabolites, which may have beneficial or adverse effects on human health, as largely described is recent reviews [44 ,45,46 ] . Other authors [47 ] have elegantly discussed the role of the microbiota as a significant determinant of cardiovascular disease risk.
Conclusion
The recognition that gut microflora may play an important role in maintaining human health led the scientific community to consider the means by which gut microflora may be manipulated. Molecular methods for the quantification of bacteria have led to a major revision of the description of the human gut microbiota in the last 5 years, and will constitute an interesting tool for assessing microbiota complexity in the near future. The evidence that the gut microbiota composition can be different between healthy or obese and type 2 diabetes patients has led to gut microflora being thought of as a possible link and as an additional factor in the pathophysiology of metabolic diseases. Different and complementary mechanisms may be proposed, however, to explain the metabolic shift towards energy storage involving the gut microbiota in obese individuals (Fig. 1) : firstly, the gut microbiota increases the capacity for an individual to harvest energy from the diet; secondly, the gut microbiota controls triacylglycerol fate (FIAF theory); and thirdly, the modulation of gut microbiota increases plasma lipopolysaccharide levels which trigger the inflammatory tone and the onset of obesity and type 2 diabetes. Nevertheless, a number of questions on how and why the composition of gut microbiota may be associated with obesity and other nutritional disorders will have to be answered. Finally, specific strategies for modifying gut microbiota (in favor of bifidobacteria?) may be a useful means to reduce the impact of high-fat feeding on the occurrence of metabolic diseases.
